Recent Posts

Research: Are there patterns to successful biotech innovation?

Jan 22, 2014 by
Fred D. Ledley
Laura McNamee

Innovation in biotechnology is often portrayed as being wildly complex and unpredictable. Recent research from the Center for Integration of Science and Industry suggests that there are patterns in the timelines of technological maturation and successful development of therapeutic biotechnologies that are predictable from innovation theory.

Research: Why commercialization of gene therapy stalled

Jan 22, 2014 by
Fred D. Ledley
Laura McNamee

It has been 40 years since recombinant technologies first enabled consideration of gene therapy for human disease, and 30 years since the first gene therapy companies were formed. Yet, there are no gene therapies on the market in the US or EU. A recent research paper from the Center for Integration of Science and Industry explores how asynchrony between capital investments and the maturation of gene therapy technologies may have contributed to this delay.

Blog: Biotech is not just for geeks

Nov 22, 2013 by
Fred D. Ledley

As biotechnology matures, business professionals have an increasingly important role in the industry. These individuals need to have interdisciplinary understanding of the nature of science and technology, the process of technology innovation and implementation, and the strategic role of technology in business. Fred Ledley addresses the challenges of educating scientifically literate business professions on Bentley University’s IMPACT.

Blog: Can changes in accounting for R&D promote innovation?

Nov 18, 2013 by
Fred D. Ledley
GDP figure

Recent revisions in how R&D is represented in calculating the Gross Domestic Product (GDP) added ½ trillion dollars to measures of the US economy. Fred Ledley anticipates that similar changes in accounting standards could significantly increase the recognized value of innovation on Bentley University’s IMPACT.

Pages